Medicon Valley Alliance and Fios Genomics are pleased to invite you to a Good Morning Meeting on the 28th of October 2025 in Copenhagen.
The road to new therapies is long, costly, and full of risk, but smarter use of data can change the odds. This session will explore how bioinformatics can drive success in pre-clinical and clinical development, from target validation using public datasets to identifying early biomarkers of efficacy and response. Discover how data-driven insights can boost the chances of success or help projects fail fast and fail cheaper.
Date: Tuesday 28th of October 2025
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2
Program
| 8:30 | Networking, registration and light breakfast |
| 9:00 | Welcome and introduction to Medicon Valley Alliance David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 9:05 | Welcome and introduction to Fios Genomics Tom Ng, PhD, Business Development (Nordics, Netherlands and UK), Fios Genomics |
| 9:15 | De-Risking Drug Development with Data-Driven Decision Making Thomas Bleazard, PhD, Senior Bioinformatician, Fios Genomics Tom Ng, PhD, Business Development (Nordics, Netherlands and UK), Fios Genomics |
| 10:00 | Networking |
| 11:00 | End of Good Morning Meeting |
Speakers
 |
Tom Ng, PhD, Business Development (Nordics, Netherlands and UK), Fios Genomics
Tom Ng is responsible for supporting the scientific research of companies based in the Nordics, as well as those in the Netherlands and UK. With an expertise in neuroscience, he combines excellent scientific knowledge with strong communication skills to align Fios’ extensive bioinformatics capabilities with the strategic needs of clients to enable faster, smarter decision-making in drug discovery and development. Tom obtained his PhD and MSc in Neuroscience from the University of Edinburgh. |
 |
Thomas Bleazard, PhD, Senior Bioinformatician, Fios Genomics
Thomas Bleazard is a Senior Bioinformatician specializing in cancer genomics with expertise in next-generation sequencing (NGS) and pipeline development. He has also published across areas including small RNA analysis, metagenomics, viral dynamics and gene fusion. Since taking up the position of Senior Bioinformatician at Fios in 2023, Thomas has led the analysis of over 40 projects spanning a range of indications and stages of development. Prior to working at Fios, Thomas also worked as a bioinformatician at the Medicines and Healthcare Products Regulatory Agency (MHRA). He obtained his PhD and MSc in Bioinformatics from the University of Manchester and Seoul National University.
|
| Organized by | In collaboration with |
 |
 |